Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Renal Cell × Magnetic Resonance Imaging × Clear all

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 15 Breast Neoplasms 9 Brain Neoplasms 6 Neoplasms 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Urinary Bladder Neoplasms 3 Spinal Cord Neoplasms 3 Multiple Myeloma 2 Lymphoma, B-Cell 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vasculitis 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocythemia, Essential 1 Thoracic Neoplasms 1 Thoracic Diseases 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Diseases 1 Solid Tumor, Adult 1 Sinusitis 1 Sarcoma 1

Interventions

Sunitinib 72 Sorafenib 52 Everolimus 44 pazopanib 42 Nivolumab 42 Bevacizumab 39 pembrolizumab 31 aldesleukin 26 Interferon-alpha 26 temsirolimus 23 cabozantinib 19 Axitinib 19 Ipilimumab 16 Interleukin-2 15 Cyclophosphamide 15 fludarabine phosphate 13 Interferon alpha-2 13 Gemcitabine 13 Peripheral Blood Stem Cell Transplantation 10 Paclitaxel 10 Erlotinib Hydrochloride 10 Sirolimus 9 Docetaxel 8 Capecitabine 8 tremelimumab 7 lenvatinib 7 Radiosurgery 7 Fluorouracil 7 Fluorodeoxyglucose F18 7 Cyclosporine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02325921 2020-02-24

MRI in Renal Tumors

Radboud University Medical Center

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡